Author

Travis Vander Steen

Observed name: T. Vander Steen

Institution: Mayo Clinic

Observed institutions: Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota)

OpenAlex ID: A5019733589

Fatty acid synthase (FASN) regulates the mitochondrial priming of cancer cells

2021 · Barbara Schroeder, Travis Vander Steen, et al. · Cell Death and Disease · 97

Fatty Acid Synthase Confers Tamoxifen Resistance to ER+/HER2+ Breast Cancer

2021 · Javier A. Menendez, Adriana Papadimitropoulou, et al. · Cancers · 41

Fatty acid synthase ( FASN ) signalome: A molecular guide for precision oncology

2023 · Javier A. Menendez, Elisabet Cuyàs, et al. · Molecular Oncology · 31

Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer

2020 · Javier A. Menendez, Inderjit Mehmi, et al. · International Journal of Molecular Sciences · 30

Fatty acid synthase (FASN) inhibition cooperates with BH3 mimetic drugs to overcome resistance to mitochondrial apoptosis in pancreatic cancer

2025 · Travis Vander Steen, Ingrid Espinoza, et al. · Neoplasia · 16

Depletion of CCN1/CYR61 reduces triple-negative/basal-like breast cancer aggressiveness.

2022 · Ingrid Espinoza, Chandra Kurapaty, et al. · PubMed · 16

Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α6β1 drives endocrine resistance in breast cancer cells

2022 · Ingrid Espinoza, Lin Yang, et al. · Aging · 11

Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer

2020 · Adriana Papadimitropoulou, Luciano Vellon, et al. · International Journal of Molecular Sciences · 11

Progesterone receptor isoform-dependent cross-talk between prolactin and fatty acid synthase in breast cancer

2020 · Javier A. Menendez, Susan K. Peirce, et al. · Aging · 7

Abstract PS5-01-16: Phase II Trial of the FASN Inhibitor, Denifanstat (TVB-2640), Plus Trastuzumab in Combination with Paclitaxel or Endocrine Therapy (ET) in Patients with HER2+ Metastatic Breast Cancer (MBC) Resistant to Trastuzumab

2026 · T. C. Haddad, V. J. Suman, et al. · Clinical Cancer Research · 2

Nuclear moonlighting of the secreted growth factor heregulin drives endocrine-resistant breast cancer independently of HER2/HER3 signaling.

2022 · Lin Yang, Travis Vander Steen, et al. · PubMed · 1

Abstract 318: Inhibition of FASN induces apoptosis and senescence in breast cancer

2018 · Travis Vander Steen, Ruth Lupu · Cancer Research · 1

Fatty Acid Synthase (Fasn) Inhibition Cooperates with Bh3 Mimetic Drugs to Overcome Resistance to Mitochondrial Apoptosis in Pancreatic Cancer

2024 · Javier Menendez, Travis Vander Steen, et al. · SSRN Electronic Journal

Abstract 3723: Fatty acid synthase: A new therapeutic target for pancreatic cancer

2019 · Travis Vander Steen, Li Ding, et al. · Tumor Biology

Abstract 3723: Fatty acid synthase: A new therapeutic target for pancreatic cancer

2019 · Travis Vander Steen, Li Ding, et al. · Cancer Research

Quantification of Malondialdehyde in Exercise Participants

2005 · Travis Vander Steen · Cornerstone (Minnesota State University, Mankato)

Works count: 16

Citation count: 264

H-index: 8

I10-index: 8